ABD-RABOU, A.; AHMED, H.; ESKANDER, E. CLEMASTINE, THE H1 HISTAMINE RECEPTOR ANTAGONIST, ALTERS THE HUMAN SEX AND THYROID HORMONAL PROFILES. Asian Journal of Pharmaceutical and Clinical Research, v. 10, n. 8, p. 327-330, 1 Aug. 2017.